Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPravin herlekar

    Pravin Herlekar

    Jump to

    • Omkar Speciality gets patent for beta ketoester chemical process

      Pravin Herlekar, Chairman and Managing Director of the company told CNBC-TV18 that the patent, fourth one for the firm, is for beta ketoester chemical. There are seven more patents in the pipeline, he added.

    • Margins can sustain at current levels: Omkar Speciality

      A diversified product and customer portfolio leading to lower dependence on any particular product or customer gives Omkar Speciality the confidence of sustaining healthy margins, says Chairman and Managing Director Pravin Herlekar.

    • Omkar Speciality Chemicals eyes 20-25% rev growth in FY15

      Speciality chemicals manufacturer eyes revenue growth of 20-25 percent in FY15, says CMD Pravin Herlekar, adding that the company will maintain profit after tax (PAT) margins of 7-8 percent in this fiscal, which will improve in FY16.

    • Omkar Speciality has growth plans for new purchase LASA Lab

      Pravin Herlekar, the chairman and managing director of Omkar Speciality Chemicals says LASA Lab is an attractive buy for the company as it is an established player in the API segment.

    • To garner major revenue in FY12-13: Omkar Speciality

      In an exclusive interview with CNBC-TV18’s Udayan Mukherjee and Mitali Mukherjee, Pravin Herlekar, Chairman and Managing Director of Omkar Speciality Chemicals says that the company sees the FY11 revenues to be at Rs 100 crore.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347